[1]
E. S. PEREIRA, R. A. SOUZA, A. P. SFORSIN, and V. B. PINTO, “Assessment of the Economic Impact of Warfarin Substitution with Rivaroxaban”, J Hosp Pharm Health Serv, vol. 17, no. 1, p. e1311, Apr. 2026.